(Q40870299)

English

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

scientific article published on December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group (English)

1 reference

Europe PubMed Central

24 September 2017

multicenter clinical trial

0 references

1

object named as

Jones RN

1 reference

Europe PubMed Central

24 September 2017

Michael A. Pfaller

3

object named as

Pfaller MA

1 reference

Europe PubMed Central

24 September 2017

author name string

Salazar JC

2

1 reference

Europe PubMed Central

24 September 2017

Doern GV

4

1 reference

Europe PubMed Central

24 September 2017

publication date

1 December 1997

1 reference

Europe PubMed Central

24 September 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

24 September 2017

29

1 reference

Europe PubMed Central

24 September 2017

4

1 reference

Europe PubMed Central

24 September 2017

265-272

1 reference

Europe PubMed Central

24 September 2017

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the E test, a novel method of quantifying antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Pneumococcal Study Group in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefepime as treatment for osteomyelitis and other severe bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A new therapeutic option for the treatment of pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of resistance to cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Current and future management of serious skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900157-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(97)00157-0

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40870299&oldid=1959536196"